Literature DB >> 8193350

Characterization of genomic PIG-A gene: a gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria.

Y Iida1, J Takeda, T Miyata, N Inoue, J Nishimura, T Kitani, K Maeda, T Kinoshita.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia characterized by the presence of abnormal subpopulations of blood cells that are deficient in surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins. Recent studies showed that the gene termed PIG-A, which participates in the first step of GPI-anchor biosynthesis, is mutated in the abnormal blood cells from patients with PNH. In this study the genomic PIG-A gene was cloned and characterized to obtain nucleotide sequence information for analyzing somatic mutations of PIG-A in patients with PNH. The PIG-A gene is at least 17 kb long and has six exons. The exon-intron boundaries and 583 bp of the 5' flanking region were sequenced. The 5' flanking region has no TATA-like sequence, but includes four CAAT boxes, two AP-2 sequences, and a CRE sequence, some of which are present in regions necessary for the promoter activity. We report pairs of oligonucleotide primers for polymerase chain reaction that should be useful to amplify and analyze various regions of the PIG-A gene in patients with PNH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193350

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  The genetic defect of PNH.

Authors:  T Kinoshita
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

2.  Pig-a gene mutation assay study design: critical assessment of 3- versus 28-day repeat-dose treatment schedules.

Authors:  Azeddine Elhajouji; Tamsanqa Tafara Hove; Oliver O'Connell; Hansjoerg Martus; Stephen D Dertinger
Journal:  Mutagenesis       Date:  2020-09-12       Impact factor: 3.000

3.  Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.

Authors:  V C Taylor; M Sims; S Brett; M C Field
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

Review 4.  Biosynthesis of glycosylphosphatidylinositol membrane anchors.

Authors:  V L Stevens
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 5.  Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms.

Authors:  J P Atkinson; M Krych; M Nickells; D Birmingham; V B Subramanian; L Clemenza; J Alvarez; K Liszewski
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 6.  Paroxysmal nocturnal haemoglobinuria: nature's gene therapy?

Authors:  R J Johnson; P Hillmen
Journal:  Mol Pathol       Date:  2002-06

7.  A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.

Authors:  D E Dunn; J Yu; S Nagarajan; M Devetten; F F Weichold; M E Medof; N S Young; J M Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients.

Authors:  A Savoia; L Ianzano; C Lunardi; G De Sandre; M Carotenuto; P Musto; L Zelante
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

9.  Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.

Authors:  S Bellone; D Roque; E Cocco; S Gasparrini; I Bortolomai; N Buza; M Abu-Khalaf; D-A Silasi; E Ratner; M Azodi; P E Schwartz; T J Rutherford; S Pecorelli; A D Santin
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

10.  Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.

Authors:  Nader Omidvar; Eddie C Y Wang; Paul Brennan; M Paula Longhi; Richard A G Smith; B Paul Morgan
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.